Summit Therapeutics (SMMT) Asset Utilization Ratio (2020 - 2023)

Summit Therapeutics (SMMT) has 4 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q2 2023.

• Quarterly Asset Utilization Ratio fell 95.36% year-over-year to 0.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.0 (down 95.36% YoY) and the FY2022 annual result came in at 0.0, down 89.18% from the prior year.
• Asset Utilization Ratio retreated to 0.0 in Q2 2023, from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2022 to a low of 0.0 in Q2 2023.
• A 4-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 348.67% — and 2023, when it plunged 95.36%.
• Tracing SMMT's Asset Utilization Ratio over 4 years: stood at 0.01 in 2020, then soared by 38.49% to 0.01 in 2021, then tumbled by 88.49% to 0.0 in 2022, then tumbled by 48.05% to 0.0 in 2023.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022), per Business Quant data.